Akso Health Group (NASDAQ: AHG) operates in the dynamic healthcare sector as a medical distribution company headquartered in Qingdao, China. With a market capitalization of $976.64 million, Akso Health Group..
Sionna Therapeutics, Inc. (NASDAQ: SION) has caught the attention of investors with its striking 328.57% potential upside as indicated by the average target price set by analysts. For a company..
Cogent Biosciences, Inc. (NASDAQ: COGT), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline of precision therapies aimed at genetically defined diseases...
Kura Oncology, Inc. (NASDAQ: KURA) is capturing the attention of investors with its compelling growth potential in the biotechnology sector. As a clinical-stage biopharmaceutical company, Kura is focused on developing..
AxoGen, Inc. (NASDAQ: AXGN), a pioneer in the healthcare sector specializing in medical devices for peripheral nerve repair, presents a compelling investment opportunity with its promising growth trajectory and robust..
Spyre Therapeutics, Inc. (NASDAQ: SYRE) is capturing the attention of investors with its promising pipeline in the biotechnology sector, particularly in the treatment of inflammatory bowel disease (IBD) and rheumatic..
OrthoPediatrics Corp. (NASDAQ: KIDS) presents a compelling opportunity for investors keen on the healthcare sector, specifically within the niche market of pediatric orthopedic medical devices. With a market capitalization of..
InMode Ltd. (NASDAQ: INMD) has carved a niche in the healthcare sector, particularly within the medical devices industry. The Israel-based company is renowned for its innovative aesthetic medical products, leveraging..
Investors with a keen eye on the biotechnology sector might find Bicycle Therapeutics plc (NASDAQ: BCYC) an intriguing prospect, especially given its substantial potential upside of 149.34%. This UK-based clinical-stage..
Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a notable entity in the healthcare sector specializing in drug manufacturing, is catching the attention of savvy investors with its impressive potential upside of 121.62%...
iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector specializing in medical devices, offers a compelling opportunity for investors seeking exposure to the niche market of MRI-compatible equipment...
GH Research PLC (NASDAQ: GHRS), an emerging player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 109.73%, according to recent analyst ratings. Specializing in..
Investors looking to delve into the biotechnology sector may find ArriVent BioPharma, Inc. (NASDAQ: AVBP) an intriguing prospect. With a market cap of $823.93 million, this clinical-stage biopharmaceutical company is..
Investors with a keen eye on the biotechnology sector might find Enliven Therapeutics, Inc. (NASDAQ: ELVN) an intriguing prospect. With a market capitalization of $2.98 billion, this clinical-stage biopharmaceutical company..
Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage biopharmaceutical company based in San Francisco, is capturing significant investor attention with its impressive potential upside of 88.85% and a unanimous Buy rating..
AnaptysBio, Inc. (NASDAQ: ANAB) stands out as a compelling investment opportunity in the biotechnology sector, with analysts forecasting a significant potential upside of 88.81%. The company, based in San Diego,..
Keros Therapeutics, Inc. (NASDAQ: KROS) is capturing investor attention due to its substantial growth potential, as reflected in its significant 70.39% potential upside according to analyst ratings. As a clinical-stage..
Immatics N.V. (NASDAQ: IMTX), a German biotechnology firm specializing in innovative cancer treatments, is capturing the attention of investors with its promising outlook. As a clinical-stage biopharmaceutical company, Immatics focuses..
Investors eyeing the biotechnology sector might find Zymeworks Inc. (NASDAQ: ZYME) an intriguing prospect, given its significant potential upside and unanimous analyst endorsements. With a current market capitalization of $1.81..
